Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 16, 2020 Filed Dec 18, 2020 21:57 UTC |
Rivera Kim MPresident SBM, CLO & Sec
|
SaleCommon Stock | 48,332 | $24.21 | $1,170,117.72 |
DisclosureSEC source: 0001562180-20-007362 · primarydocument.xml · nonDerivative · entry 1 Rivera Kim M · CIK 0001479038 · President SBM, CLO & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,208 F1 · shares: The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on12/23/2019 Read SEC document |
| December 09, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
SaleCommon Stock | 48,755 | $23.16 | $1,129,165.80 |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · nonDerivative · entry 3 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,854 F3 · price: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/21/2020. Read SEC document |
| December 09, 2020 Filed Jan 12, 2021 22:28 UTC Amendment |
Schell ChristophChief Commercial Officer
|
SaleCommon Stock | 48,782 | $23.16 | $1,129,791.12 |
DisclosureSEC source: 0001562180-21-000323 · primarydocument.xml · nonDerivative · entry 1 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,827 F1 · price: The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 09/21/2020. F2 · balance_after: This amendment is being filed to correct the original Form 4 filed December 9, 2020. The number of shares sold pursuant to the Reporting Person's 10b5-1 Plan were incorrect on the original Form 4 due to an administrative error by the Reporting Person's broker. The number of shares sold were incorrectly reported as 48,755 and have been corrected to 48,782 in this amended Form 4. In addition, the total number of shares owned in Column 5 has been reduced by 27 shares to reflect the correct number of shares held by the reporting person after this transaction. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
Tran TuanPresident of Printing
|
Exercise / conversionRestricted Stock Units · Derivative | 17,428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007142 · primarydocument.xml · derivative · entry 8 Tran Tuan · CIK 0001793233 · President of Printing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On 12/7/2017, the reporting person was granted 47,687 RSUs, 15,895 of which vested on 12/7/2018 and 15,896 of which vested on 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,532 vested dividend equivalent rights. F8 · price: On 12/7/2017, the reporting person was granted 47,687 RSUs, 15,895 of which vested on 12/7/2018 and 15,896 of which vested on 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,532 vested dividend equivalent rights. F8 · derivative.exercise_date: On 12/7/2017, the reporting person was granted 47,687 RSUs, 15,895 of which vested on 12/7/2018 and 15,896 of which vested on 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,532 vested dividend equivalent rights. F8 · derivative.expiration_date: On 12/7/2017, the reporting person was granted 47,687 RSUs, 15,895 of which vested on 12/7/2018 and 15,896 of which vested on 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,532 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
Tran TuanPresident of Printing
|
Exercise / conversionRestricted Stock Units · Derivative | 14,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007142 · primarydocument.xml · derivative · entry 7 Tran Tuan · CIK 0001793233 · President of Printing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,084 Underlying: Common Stock · 14,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On 12/7/2018, the reporting person was granted 39,250 RSUs, 13,083 of which vested on 12/7/2019 and 12/7/2020 and of which 13,084 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 942 vested dividend equivalent rights. F7 · price: On 12/7/2018, the reporting person was granted 39,250 RSUs, 13,083 of which vested on 12/7/2019 and 12/7/2020 and of which 13,084 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 942 vested dividend equivalent rights. F7 · derivative.exercise_date: On 12/7/2018, the reporting person was granted 39,250 RSUs, 13,083 of which vested on 12/7/2019 and 12/7/2020 and of which 13,084 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 942 vested dividend equivalent rights. F7 · derivative.expiration_date: On 12/7/2018, the reporting person was granted 39,250 RSUs, 13,083 of which vested on 12/7/2019 and 12/7/2020 and of which 13,084 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 942 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
Tran TuanPresident of Printing
|
Exercise / conversionRestricted Stock Units · Derivative | 30,436 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007142 · primarydocument.xml · derivative · entry 6 Tran Tuan · CIK 0001793233 · President of Printing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,537 Underlying: Common Stock · 30,436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: On 12/6/2019, the reporting person was granted 87,805 RSUs, 29,268 of which vested on 12/7/2020, and of which 29,268 is scheduled to vest on 12/7/2021 and of which 29,269 is scheduled to vest 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,168 vested dividend equivalent rights. F6 · price: On 12/6/2019, the reporting person was granted 87,805 RSUs, 29,268 of which vested on 12/7/2020, and of which 29,268 is scheduled to vest on 12/7/2021 and of which 29,269 is scheduled to vest 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,168 vested dividend equivalent rights. F6 · derivative.exercise_date: On 12/6/2019, the reporting person was granted 87,805 RSUs, 29,268 of which vested on 12/7/2020, and of which 29,268 is scheduled to vest on 12/7/2021 and of which 29,269 is scheduled to vest 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,168 vested dividend equivalent rights. F6 · derivative.expiration_date: On 12/6/2019, the reporting person was granted 87,805 RSUs, 29,268 of which vested on 12/7/2020, and of which 29,268 is scheduled to vest on 12/7/2021 and of which 29,269 is scheduled to vest 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,168 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
Tran TuanPresident of Printing
|
GrantPerformance Contingent Stock Options · Derivative | 259,706 | Not disclosed Strike: $23.68 | Not disclosed |
DisclosureSEC source: 0001562180-20-007142 · primarydocument.xml · derivative · entry 5 Tran Tuan · CIK 0001793233 · President of Printing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,706 Underlying: Common Stock · 259,706 shares Expires not disclosed F5 · price: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · derivative.exercise_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · derivative.expiration_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
Tran TuanPresident of Printing
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 58,559 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007142 · primarydocument.xml · derivative · entry 4 Tran Tuan · CIK 0001793233 · President of Printing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,559 Underlying: Common Stock · 58,559 shares Expires not disclosed F4 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 59,559 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 59,559 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 59,559 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
Tran TuanPresident of Printing
|
GrantRestricted Stock Units · Derivative | 92,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007142 · primarydocument.xml · derivative · entry 3 Tran Tuan · CIK 0001793233 · President of Printing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,905 Underlying: Common Stock · 92,905 shares Expires not disclosed F3 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 92,905 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 92,905 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 92,905 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
Tran TuanPresident of Printing
|
Tax withholdingCommon Stock | 18,107 | $23.68 | $428,773.76 |
DisclosureSEC source: 0001562180-20-007142 · primarydocument.xml · nonDerivative · entry 2 Tran Tuan · CIK 0001793233 · President of Printing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,680 F2 · shares: 18,107 shares were withheld by HP to satisfy tax withholding on vesting of RSUs. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
Tran TuanPresident of Printing
|
Exercise / conversionCommon Stock | 61,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007142 · primarydocument.xml · nonDerivative · entry 1 Tran Tuan · CIK 0001793233 · President of Printing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each RSU represents a contingent right to receive one share of HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
BRAMLEY CLAIREController
|
Exercise / conversionRestricted Stock Units · Derivative | 6,971 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007143 · primarydocument.xml · derivative · entry 7 BRAMLEY CLAIRE · CIK 0001759953 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,971 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On 12/7/2017, the reporting person was granted 19,075 RSUs, 6,358 of which vested on 12/7/2018 and 12/7/2019 and 6,359 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 612 vested dividend equivalent rights. F7 · price: On 12/7/2017, the reporting person was granted 19,075 RSUs, 6,358 of which vested on 12/7/2018 and 12/7/2019 and 6,359 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 612 vested dividend equivalent rights. F7 · derivative.exercise_date: On 12/7/2017, the reporting person was granted 19,075 RSUs, 6,358 of which vested on 12/7/2018 and 12/7/2019 and 6,359 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 612 vested dividend equivalent rights. F7 · derivative.expiration_date: On 12/7/2017, the reporting person was granted 19,075 RSUs, 6,358 of which vested on 12/7/2018 and 12/7/2019 and 6,359 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 612 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
BRAMLEY CLAIREController
|
Exercise / conversionRestricted Stock Units · Derivative | 12,467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007143 · primarydocument.xml · derivative · entry 6 BRAMLEY CLAIRE · CIK 0001759953 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,630 Underlying: Common Stock · 12,467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: On 12/7/2018, the reporting person was granted 34,889 RSUs, 11,629 which vested on 12/7/2019 and of which 11,630 vested on 12/7/2020 and of which 11,630 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 837 vested dividend equivalent rights. F6 · price: On 12/7/2018, the reporting person was granted 34,889 RSUs, 11,629 which vested on 12/7/2019 and of which 11,630 vested on 12/7/2020 and of which 11,630 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 837 vested dividend equivalent rights. F6 · derivative.exercise_date: On 12/7/2018, the reporting person was granted 34,889 RSUs, 11,629 which vested on 12/7/2019 and of which 11,630 vested on 12/7/2020 and of which 11,630 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 837 vested dividend equivalent rights. F6 · derivative.expiration_date: On 12/7/2018, the reporting person was granted 34,889 RSUs, 11,629 which vested on 12/7/2019 and of which 11,630 vested on 12/7/2020 and of which 11,630 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 837 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
BRAMLEY CLAIREController
|
Exercise / conversionRestricted Stock Units · Derivative | 7,792 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007143 · primarydocument.xml · derivative · entry 5 BRAMLEY CLAIRE · CIK 0001759953 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,269 Underlying: Common Stock · 7,792 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: On 12/7/2018, the reporting person was granted 21,805 RSUs, 7,268 which vested on 12/7/2019 and 12/7/2020 and of which 7,269 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 524 vested dividend equivalent rights. F5 · price: On 12/7/2018, the reporting person was granted 21,805 RSUs, 7,268 which vested on 12/7/2019 and 12/7/2020 and of which 7,269 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 524 vested dividend equivalent rights. F5 · derivative.exercise_date: On 12/7/2018, the reporting person was granted 21,805 RSUs, 7,268 which vested on 12/7/2019 and 12/7/2020 and of which 7,269 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 524 vested dividend equivalent rights. F5 · derivative.expiration_date: On 12/7/2018, the reporting person was granted 21,805 RSUs, 7,268 which vested on 12/7/2019 and 12/7/2020 and of which 7,269 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 524 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
BRAMLEY CLAIREController
|
Exercise / conversionRestricted Stock Units · Derivative | 13,528 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007143 · primarydocument.xml · derivative · entry 4 BRAMLEY CLAIRE · CIK 0001759953 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,016 Underlying: Common Stock · 13,528 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: On 12/6/2019, the reporting person was granted 39,024 RSUs, 13,008 of which vested on 12/7/2020, and of which 13,008 scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 520 ested dividend equivalent rights. F4 · price: On 12/6/2019, the reporting person was granted 39,024 RSUs, 13,008 of which vested on 12/7/2020, and of which 13,008 scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 520 ested dividend equivalent rights. F4 · derivative.exercise_date: On 12/6/2019, the reporting person was granted 39,024 RSUs, 13,008 of which vested on 12/7/2020, and of which 13,008 scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 520 ested dividend equivalent rights. F4 · derivative.expiration_date: On 12/6/2019, the reporting person was granted 39,024 RSUs, 13,008 of which vested on 12/7/2020, and of which 13,008 scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 520 ested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
BRAMLEY CLAIREController
|
GrantRestricted Stock Units · Derivative | 52,787 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007143 · primarydocument.xml · derivative · entry 3 BRAMLEY CLAIRE · CIK 0001759953 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,787 shares Expires not disclosed F3 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 52,787 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · price: On 12/7/2020, the reporting person was granted 52,787 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 52,787 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 52,787 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
BRAMLEY CLAIREController
|
Tax withholdingCommon Stock | 17,384 | $23.68 | $411,653.12 |
DisclosureSEC source: 0001562180-20-007143 · primarydocument.xml · nonDerivative · entry 2 BRAMLEY CLAIRE · CIK 0001759953 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,374 F2 · shares: 17,384 shares were withheld by HP to satisfy tax withholding on vesting of RSUs. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:19 UTC |
BRAMLEY CLAIREController
|
Exercise / conversionCommon Stock | 40,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007143 · primarydocument.xml · nonDerivative · entry 1 BRAMLEY CLAIRE · CIK 0001759953 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each RSU represents a contingent right to receive one share of HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 26,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · derivative · entry 9 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: On 12/7/2017, the reporting person was granted 73,057 RSUs, 24,352 of which vested on 12/7/2018 and 12/7/2019 and 24,353 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,347 vested dividend equivalent rights. F9 · derivative.exercise_date: On 12/7/2017, the reporting person was granted 73,057 RSUs, 24,352 of which vested on 12/7/2018 and 12/7/2019 and 24,353 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,347 vested dividend equivalent rights. F9 · derivative.expiration_date: On 12/7/2017, the reporting person was granted 73,057 RSUs, 24,352 of which vested on 12/7/2018 and 12/7/2019 and 24,353 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,347 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 31,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · derivative · entry 8 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,074 Underlying: Common Stock · 31,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On 12/7/2018, the reporting person was granted 87,222 RSUs, 29,074 of which vested on 12/7/2017, 12/7/2018 and 12/7/2019. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,092 vested dividend equivalent rights. F8 · derivative.exercise_date: On 12/7/2018, the reporting person was granted 87,222 RSUs, 29,074 of which vested on 12/7/2017, 12/7/2018 and 12/7/2019. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,092 vested dividend equivalent rights. F8 · derivative.expiration_date: On 12/7/2018, the reporting person was granted 87,222 RSUs, 29,074 of which vested on 12/7/2017, 12/7/2018 and 12/7/2019. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,092 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 38,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · derivative · entry 7 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,797 Underlying: Common Stock · 38,890 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On 12/6/2019, the reporting person was granted 112,195 RSUs, 37,398 of which vested on 12/7/2020, and of which 37,398 is scheduled to vest on 12/7/2021 and of which 37,399 is scheduled to vest 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,492 vested dividend equivalent rights. F7 · derivative.exercise_date: On 12/6/2019, the reporting person was granted 112,195 RSUs, 37,398 of which vested on 12/7/2020, and of which 37,398 is scheduled to vest on 12/7/2021 and of which 37,399 is scheduled to vest 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,492 vested dividend equivalent rights. F7 · derivative.expiration_date: On 12/6/2019, the reporting person was granted 112,195 RSUs, 37,398 of which vested on 12/7/2020, and of which 37,398 is scheduled to vest on 12/7/2021 and of which 37,399 is scheduled to vest 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,492 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
GrantPerformance Contingent Stock Option · Derivative | 306,925 | Not disclosed Strike: $23.68 | Not disclosed |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · derivative · entry 6 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,925 Underlying: Common Stock · 306,925 shares Expires not disclosed F6 · price: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F6 · derivative.exercise_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F6 · derivative.expiration_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 69,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · derivative · entry 5 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,206 Underlying: Common Stock · 69,206 shares Expires not disclosed F5 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 69,206 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F5 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 69,206 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F5 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 69,206 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 109,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · derivative · entry 4 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,797 Underlying: Common Stock · 109,797 shares Expires not disclosed F4 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 109,797 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F4 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 109,797 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F4 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 109,797 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
Tax withholdingCommon Stock | 47,974 | $23.68 | $1,136,024.32 |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · nonDerivative · entry 2 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,609 F2 · shares: 47,974 shares were withheld by HP to satisfy tax withholding on vesting of RSUs. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:18 UTC |
Schell ChristophChief Commercial Officer
|
Exercise / conversionCommon Stock | 96,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007141 · primarydocument.xml · nonDerivative · entry 1 Schell Christoph · CIK 0001793234 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each RSU represents a contingent right to receive one share of HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
KEOGH TRACY SChief HR Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 21,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007140 · primarydocument.xml · derivative · entry 8 KEOGH TRACY S · CIK 0001234596 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,926 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On 12/7/2017, the reporting person was granted 62,661 RSUs, 20,887 of which vested on 12/7/2018, 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,039 vested dividend equivalent rights. F8 · price: On 12/7/2017, the reporting person was granted 62,661 RSUs, 20,887 of which vested on 12/7/2018, 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,039 vested dividend equivalent rights. F8 · derivative.exercise_date: On 12/7/2017, the reporting person was granted 62,661 RSUs, 20,887 of which vested on 12/7/2018, 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,039 vested dividend equivalent rights. F8 · derivative.expiration_date: On 12/7/2017, the reporting person was granted 62,661 RSUs, 20,887 of which vested on 12/7/2018, 12/7/2019 and 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,039 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
KEOGH TRACY SChief HR Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 21,817 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007140 · primarydocument.xml · derivative · entry 7 KEOGH TRACY S · CIK 0001234596 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,352 Underlying: Common Stock · 21,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On 12/7/2018, the reporting person was granted 61,055 RSUs, 20,351 which vested on 12/7/2019 and of which 20,352 vested on 12/7/2020 and of which 20,352 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,465 vested dividend equivalent rights. F7 · price: On 12/7/2018, the reporting person was granted 61,055 RSUs, 20,351 which vested on 12/7/2019 and of which 20,352 vested on 12/7/2020 and of which 20,352 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,465 vested dividend equivalent rights. F7 · derivative.exercise_date: On 12/7/2018, the reporting person was granted 61,055 RSUs, 20,351 which vested on 12/7/2019 and of which 20,352 vested on 12/7/2020 and of which 20,352 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,465 vested dividend equivalent rights. F7 · derivative.expiration_date: On 12/7/2018, the reporting person was granted 61,055 RSUs, 20,351 which vested on 12/7/2019 and of which 20,352 vested on 12/7/2020 and of which 20,352 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,465 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
KEOGH TRACY SChief HR Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 27,055 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007140 · primarydocument.xml · derivative · entry 6 KEOGH TRACY S · CIK 0001234596 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,033 Underlying: Common Stock · 27,055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: On 12/6/2019, the reporting person was granted 78,049 RSUs, 26,016 of which vested on 12/7/2020, and of which 26,016 is scheduled to vest on 12/7/2021 and of which 26,017 is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,039 vested dividend equivalent rights. F6 · price: On 12/6/2019, the reporting person was granted 78,049 RSUs, 26,016 of which vested on 12/7/2020, and of which 26,016 is scheduled to vest on 12/7/2021 and of which 26,017 is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,039 vested dividend equivalent rights. F6 · derivative.exercise_date: On 12/6/2019, the reporting person was granted 78,049 RSUs, 26,016 of which vested on 12/7/2020, and of which 26,016 is scheduled to vest on 12/7/2021 and of which 26,017 is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,039 vested dividend equivalent rights. F6 · derivative.expiration_date: On 12/6/2019, the reporting person was granted 78,049 RSUs, 26,016 of which vested on 12/7/2020, and of which 26,016 is scheduled to vest on 12/7/2021 and of which 26,017 is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,039 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
KEOGH TRACY SChief HR Officer
|
GrantPerformance Contingent Stock Options · Derivative | 188,877 | Not disclosed Strike: $23.68 | Not disclosed |
DisclosureSEC source: 0001562180-20-007140 · primarydocument.xml · derivative · entry 5 KEOGH TRACY S · CIK 0001234596 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,877 Underlying: Common Stock · 188,877 shares Expires not disclosed F5 · price: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · derivative.exercise_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · derivative.expiration_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
KEOGH TRACY SChief HR Officer
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 42,588 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007140 · primarydocument.xml · derivative · entry 4 KEOGH TRACY S · CIK 0001234596 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,588 Underlying: Common Stock · 42,588 shares Expires not disclosed F4 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 42,588 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · price: On 12/7/2020, the reporting person was granted 42,588 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 42,588 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 42,588 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
KEOGH TRACY SChief HR Officer
|
GrantRestricted Stock Units · Derivative | 67,658 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007140 · primarydocument.xml · derivative · entry 3 KEOGH TRACY S · CIK 0001234596 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,658 Underlying: Common Stock · 67,658 shares Expires not disclosed F3 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 67,568 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · price: On 12/7/2020, the reporting person was granted 67,568 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 67,568 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 67,568 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
KEOGH TRACY SChief HR Officer
|
Tax withholdingCommon Stock | 35,588 | $23.68 | $842,723.84 |
DisclosureSEC source: 0001562180-20-007140 · primarydocument.xml · nonDerivative · entry 2 KEOGH TRACY S · CIK 0001234596 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,730 F2 · shares: 35,588 shares were withheld by HP to satisfy tax withholding on vesting of RSUs. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
KEOGH TRACY SChief HR Officer
|
Exercise / conversionCommon Stock | 71,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-007140 · primarydocument.xml · nonDerivative · entry 1 KEOGH TRACY S · CIK 0001234596 · Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each RSU represents a contingent right to receive one share of HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
MYERS MARIEActing Chief Financial Officer
|
GrantPerformance Contingent Stock Options · Derivative | 188,877 | Not disclosed Strike: $23.68 | Not disclosed |
DisclosureSEC source: 0001562180-20-007139 · primarydocument.xml · derivative · entry 3 MYERS MARIE · CIK 0001656326 · Acting Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,877 Underlying: Common Stock · 188,877 shares Expires not disclosed F3 · price: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F3 · derivative.exercise_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F3 · derivative.expiration_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
MYERS MARIEActing Chief Financial Officer
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 42,588 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007139 · primarydocument.xml · derivative · entry 2 MYERS MARIE · CIK 0001656326 · Acting Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,588 Underlying: Common Stock · 42,588 shares Expires not disclosed F2 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 42,588 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F2 · price: On 12/7/2020, the reporting person was granted 42,588 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F2 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 42,588 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F2 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 42,588 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:17 UTC |
MYERS MARIEActing Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 67,568 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007139 · primarydocument.xml · derivative · entry 1 MYERS MARIE · CIK 0001656326 · Acting Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,568 Underlying: Common Stock · 67,568 shares Expires not disclosed F1 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 67,568 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F1 · price: On 12/7/2020, the reporting person was granted 67,568 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F1 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 67,568 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F1 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 67,568 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
LORES ENRIQUEDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 34,856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007137 · primarydocument.xml · derivative · entry 8 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On 12/7/2017, the reporting person was granted 95,374 RSUs, 31,791 of which vested on 12/7/2018 and 12/7/2019 and 31,792 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 3,064 vested dividend equivalent rights. F8 · price: On 12/7/2017, the reporting person was granted 95,374 RSUs, 31,791 of which vested on 12/7/2018 and 12/7/2019 and 31,792 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 3,064 vested dividend equivalent rights. F8 · derivative.exercise_date: On 12/7/2017, the reporting person was granted 95,374 RSUs, 31,791 of which vested on 12/7/2018 and 12/7/2019 and 31,792 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 3,064 vested dividend equivalent rights. F8 · derivative.expiration_date: On 12/7/2017, the reporting person was granted 95,374 RSUs, 31,791 of which vested on 12/7/2018 and 12/7/2019 and 31,792 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 3,064 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
LORES ENRIQUEDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 35,219 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007137 · primarydocument.xml · derivative · entry 7 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,854 Underlying: Common Stock · 35,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On 12/7/2018, the reporting person was granted 98,561 RSUs, 32,853 of which vested on 12/7/2019 and of which vested 32,854 on 12/7/2020 and of which 32,854 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,365 vested dividend equivalent rights. F7 · shares: On 12/7/2018, the reporting person was granted 98,561 RSUs, 32,853 of which vested on 12/7/2019 and of which vested 32,854 on 12/7/2020 and of which 32,854 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,365 vested dividend equivalent rights. F7 · price: On 12/7/2018, the reporting person was granted 98,561 RSUs, 32,853 of which vested on 12/7/2019 and of which vested 32,854 on 12/7/2020 and of which 32,854 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,365 vested dividend equivalent rights. F7 · derivative.exercise_date: On 12/7/2018, the reporting person was granted 98,561 RSUs, 32,853 of which vested on 12/7/2019 and of which vested 32,854 on 12/7/2020 and of which 32,854 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,365 vested dividend equivalent rights. F7 · derivative.expiration_date: On 12/7/2018, the reporting person was granted 98,561 RSUs, 32,853 of which vested on 12/7/2019 and of which vested 32,854 on 12/7/2020 and of which 32,854 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,365 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
LORES ENRIQUEDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 74,398 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007137 · primarydocument.xml · derivative · entry 6 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,090 Underlying: Common Stock · 74,398 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: On 12/6/2019, the reporting person was granted 214,634 RSUs, 71,544 of which vested on 12/7/2020, and of which 71,545 is scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,854 vested dividend equivalent rights. F6 · price: On 12/6/2019, the reporting person was granted 214,634 RSUs, 71,544 of which vested on 12/7/2020, and of which 71,545 is scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,854 vested dividend equivalent rights. F6 · derivative.exercise_date: On 12/6/2019, the reporting person was granted 214,634 RSUs, 71,544 of which vested on 12/7/2020, and of which 71,545 is scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,854 vested dividend equivalent rights. F6 · derivative.expiration_date: On 12/6/2019, the reporting person was granted 214,634 RSUs, 71,544 of which vested on 12/7/2020, and of which 71,545 is scheduled to vest on 12/7/2021 and 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,854 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
LORES ENRIQUEDirector · President and CEO
|
GrantPerformance Contingent Stock Options · Derivative | 637,460 | Not disclosed Strike: $23.68 | Not disclosed |
DisclosureSEC source: 0001562180-20-007137 · primarydocument.xml · derivative · entry 5 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,460 Underlying: Common Stock · 637,460 shares Expires not disclosed F5 · price: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · derivative.exercise_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · derivative.expiration_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
LORES ENRIQUEDirector · President and CEO
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 143,735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007137 · primarydocument.xml · derivative · entry 4 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,735 Underlying: Common Stock · 143,735 shares Expires not disclosed F4 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 143,735 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · price: On 12/7/2020, the reporting person was granted 143,735 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 143,735 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 143,735 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
LORES ENRIQUEDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 228,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007137 · primarydocument.xml · derivative · entry 3 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,041 Underlying: Common Stock · 228,041 shares Expires not disclosed F3 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 228,041 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · price: On 12/7/2020, the reporting person was granted 228,041 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 228,041 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. F3 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 228,041 RSUs, one-third of which vest annually over three years on each of 12/7/2021, 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
LORES ENRIQUEDirector · President and CEO
|
Tax withholdingCommon Stock | 71,634 | $23.68 | $1,696,293.12 |
DisclosureSEC source: 0001562180-20-007137 · primarydocument.xml · nonDerivative · entry 2 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 532,050 F2 · price: 71,634 shares were withheld by HP to satisfy tax withholding on vesting of RSUs. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
LORES ENRIQUEDirector · President and CEO
|
Exercise / conversionCommon Stock | 144,473 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007137 · primarydocument.xml · nonDerivative · entry 1 LORES ENRIQUE · CIK 0001656242 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU represents a contingent right to receive one share of HP common stock. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
Rivera Kim MPresident SBM, CLO & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 23,005 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007138 · primarydocument.xml · derivative · entry 8 Rivera Kim M · CIK 0001479038 · President SBM, CLO & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,005 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: On 12/7/2017, the reporting person was granted 62,947 RSUs, 20,982 of which vested on 12/7/2018 and 12/7/2019 and 20,983 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,022 vested dividend equivalent rights. F8 · price: On 12/7/2017, the reporting person was granted 62,947 RSUs, 20,982 of which vested on 12/7/2018 and 12/7/2019 and 20,983 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,022 vested dividend equivalent rights. F8 · derivative.exercise_date: On 12/7/2017, the reporting person was granted 62,947 RSUs, 20,982 of which vested on 12/7/2018 and 12/7/2019 and 20,983 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,022 vested dividend equivalent rights. F8 · derivative.expiration_date: On 12/7/2017, the reporting person was granted 62,947 RSUs, 20,982 of which vested on 12/7/2018 and 12/7/2019 and 20,983 of which vested on 12/7/2020. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,022 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
Rivera Kim MPresident SBM, CLO & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 31,166 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007138 · primarydocument.xml · derivative · entry 7 Rivera Kim M · CIK 0001479038 · President SBM, CLO & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,074 Underlying: Common Stock · 31,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: On 12/7/2018, the reporting person was granted 87,222 RSUs, 29,074 which vested on 12/7/2019 and 12/7/2020 and of which 29,074 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,092 vested dividend equivalent rights. F7 · price: On 12/7/2018, the reporting person was granted 87,222 RSUs, 29,074 which vested on 12/7/2019 and 12/7/2020 and of which 29,074 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,092 vested dividend equivalent rights. F7 · derivative.exercise_date: On 12/7/2018, the reporting person was granted 87,222 RSUs, 29,074 which vested on 12/7/2019 and 12/7/2020 and of which 29,074 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,092 vested dividend equivalent rights. F7 · derivative.expiration_date: On 12/7/2018, the reporting person was granted 87,222 RSUs, 29,074 which vested on 12/7/2019 and 12/7/2020 and of which 29,074 is expected to vest on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,092 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
Rivera Kim MPresident SBM, CLO & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 35,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007138 · primarydocument.xml · derivative · entry 6 Rivera Kim M · CIK 0001479038 · President SBM, CLO & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,293 Underlying: Common Stock · 35,509 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: On 12/6/2019, the reporting person was granted 102,439 RSUs, 34,146 of which vested on 12/7/2020, and of which 34,146 is scheduled to vest on 12/7/2021 and of which 34,147 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,363 vested dividend equivalent rights. F6 · price: On 12/6/2019, the reporting person was granted 102,439 RSUs, 34,146 of which vested on 12/7/2020, and of which 34,146 is scheduled to vest on 12/7/2021 and of which 34,147 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,363 vested dividend equivalent rights. F6 · derivative.exercise_date: On 12/6/2019, the reporting person was granted 102,439 RSUs, 34,146 of which vested on 12/7/2020, and of which 34,146 is scheduled to vest on 12/7/2021 and of which 34,147 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,363 vested dividend equivalent rights. F6 · derivative.expiration_date: On 12/6/2019, the reporting person was granted 102,439 RSUs, 34,146 of which vested on 12/7/2020, and of which 34,146 is scheduled to vest on 12/7/2021 and of which 34,147 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,363 vested dividend equivalent rights. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
Rivera Kim MPresident SBM, CLO & Sec
|
GrantPerformance Contingent Stock Option · Derivative | 247,901 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007138 · primarydocument.xml · derivative · entry 5 Rivera Kim M · CIK 0001479038 · President SBM, CLO & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,901 Underlying: Common Stock · 247,901 shares Expires not disclosed F5 · derivative.exercise_price: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · price: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · derivative.exercise_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. F5 · derivative.expiration_date: The performance contingent stock options granted on 12/7/2020 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions being met within five years following the grant date. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 23:16 UTC |
Rivera Kim MPresident SBM, CLO & Sec
|
GrantPerformance Adjusted Restricted Stock Units · Derivative | 55,897 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-20-007138 · primarydocument.xml · derivative · entry 4 Rivera Kim M · CIK 0001479038 · President SBM, CLO & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,897 Underlying: Common Stock · 55,897 shares Expires not disclosed F4 · derivative.exercise_price: On 12/7/2020, the reporting person was granted 55,897 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · price: On 12/7/2020, the reporting person was granted 55,897 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.exercise_date: On 12/7/2020, the reporting person was granted 55,897 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. F4 · derivative.expiration_date: On 12/7/2020, the reporting person was granted 55,897 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/23, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.